Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: The prognostic accuracy of the American Joint Committee on Cancer (AJCC) 8th staging system for hypopharyngeal cancer remains uncertain. We aim to assess its survival prediction accuracy and compare it with the 7th edition.

Study Design: Retrospective investigation of prospective data.

Setting: Single-institution tertiary referral center.

Methods: A cohort of 200 patients with hypopharyngeal squamous cell carcinoma who underwent surgical intervention as primary treatment between 2007 and 2019 was analyzed. We evaluated overall survival (OS) and disease-specific survival (DSS) using the Kaplan-Meier method and the log-rank test for each AJCC edition. The Akaike information criterion (AIC) was used to assess prognostic prediction performance.

Results: The median follow-up was 67 months (29-100 months). In total, 93% of the patients (N = 186) underwent at least one side of neck dissection. In total, 41% of patients (N = 82) were upstaged as per the AJCC 8th, all resulting from the redistribution of N stage. Survival curves for DSS were better distinguished for stages I, II, and IVb in the AJCC 8th edition, yet an overlap was observed between stages III and IVa. The combination of extranodal extension (ENE) and cervical metastasis level well-differentiated the survival curves for OS and DSS. The AJCC 8th system outperformed the 7th, with lower AIC values for OS (1092 vs 1098) and DSS (654 vs 666).

Conclusion: The AJCC 8th edition improves survival prediction in hypopharyngeal cancer compared to the 7th, especially with the inclusion of ENE status and nodal metastasis classification revisions.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ohn.1311DOI Listing

Publication Analysis

Top Keywords

ajcc 8th
20
hypopharyngeal cancer
12
staging system
8
system hypopharyngeal
8
survival prediction
8
survival curves
8
curves dss
8
8th edition
8
ajcc
7
8th
6

Similar Publications

Development of a new TNM staging system for poorly differentiated thyroid carcinoma: a multicenter cohort study.

Front Endocrinol (Lausanne)

September 2025

Department of General Surgery (Thyroid Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Objective: Poorly differentiated thyroid cancer (PDTC) is a rare, heterogeneous carcinoma from follicular cells, characterized by poor differentiation, aggressive spread, and poor prognosis. Currently, there is no specific staging system for PDTC. This study aimed to develop a new TNM staging system tailored to PDTC for improved disease management.

View Article and Find Full Text PDF

Background: Hepatocellular carcinoma (HCC) remains a global health challenge, with early-stage resection offering the best chance for improved outcomes. However, limitations of the TNM staging system highlight the need for additional prognostic tools. This study evaluates the prognostic value of preoperative serum inflammatory markers in patients with stage I/II HCC undergoing surgical resection.

View Article and Find Full Text PDF

Background: Current evidence indicates an uptick in both morbidity and mortality rates of epithelial ovarian cancer (EOC) among the elderly (65 year and older) over the past few years. To date, standardized treatment for elderly patients remains undeveloped. This study utilizes the Surveillance, Epidemiology, and End Results (SEER) database to extract relevant clinicopathological data and construct two nomograms aimed at predicting the prognosis of elderly (65 year and older) patients with EOC.

View Article and Find Full Text PDF

Purpose: The American Joint Committee on Cancer (AJCC) staging system for distal cholangiocarcinoma (dCC) has evolved significantly. However, the prognostic correlation of the newly proposed staging system remains unclear. Therefore, we aimed to compare the staging performance between AJCC 7th and 8th editions for dCC.

View Article and Find Full Text PDF

Extranodal extension (ENE), defined as the pathological spread of metastatic tumor cells beyond the lymph node capsule into adjacent soft tissues, represents a critical prognostic biomarker in head and neck squamous cell carcinoma (HNSCC). Its presence correlates with aggressive tumor biology, increased risk of locoregional recurrence, distant metastasis, and reduced survival, thereby influencing staging systems and therapeutic strategies. The 8th edition of the AJCC Cancer Staging Manual has formally incorporated ENE into nodal classification for select HNSCC subsites, with the 9th edition of UICC (2025) extending this to HPV-positive oropharyngeal carcinomas.

View Article and Find Full Text PDF